CMPI Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jan 1970 @ 01:00):

Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer...

Stats
Dagens volum	63 651.00
Gjennomsnittsvolum	233 019
Markedsverdi	0.00
EPS	$-0.730 ( 2022-05-12 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.85
ATR14	$0.291 (2.77%)

Insider Trading

Date	Person	Action	Amount	type
2022-05-31	Powell Michael	Sell	30 000	Stock Option (Right to Buy)
2022-05-31	Powell Michael	Sell	10 030	Stock Option (Right to Buy)
2022-05-31	Powell Michael	Sell	30 000	Stock Option (Right to Buy)
2022-05-31	Flaherty Keith T.	Sell	10 030	Stock Option (Right to Buy)
2022-05-31	Flaherty Keith T.	Sell	4 012	Stock Option (Right to Buy)

INSIDER POWER
-100.00
Last 90 transactions
Buy: 10 162 192 \| Sell: 69 692 426

Volum Korrelasjon

Lang: 0.41 (neutral)

Kort: -0.45 (neutral)

Signal:(88.816) Neutral

Checkmate Korrelasjon

10 Mest positive korrelasjoner
WPRT	0.988
RETA	0.975
ORTX	0.973
RESN	0.969
RXDX	0.969
ACOR	0.965
ZGNX	0.965
GNLN	0.961
PBPB	0.961
ADMS	0.96

10 Mest negative korrelasjoner
EYE	-0.966
IEP	-0.958
PEBK	-0.956
PINC	-0.955
AADI	-0.951
CPTN	-0.949
MDRX	-0.949
LCUT	-0.945
PSHG	-0.944
TTEC	-0.944

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Checkmate Korrelasjon - Valuta/Råvare

0.25
( neutral )

0.73
( moderate )

0.04
( neutral )

0.15
( neutral )

-0.40
( neutral )

-0.76
( moderate negative )

Checkmate Økonomi

Annual	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-6.42

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-6.42

FY	2020
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-4.49

FY	2019
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-3.44

Financial Reports:

No articles found.

Checkmate

Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. Checkmate Pharmaceuticals, Inc. has strategic alliances with Merck KGaA and Pfizer. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. As of May 27, 2022, Checkmate Pharmaceuticals, Inc. operates as a subsidiary of Regeneron Pharmaceuticals, Inc.